AHL Partners’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
FMI
AHL Partners's DGX Position: Q4 2017 in Review
AHL Partners increased its Quest Diagnostics (DGX) stake by 14% in Q4 2017, buying an estimated $1.33M and bringing the position to 117,920 shares worth $11.6M. The position accounts for 0.18% of the portfolio, ranked #152.
AHL Partners first reported a position in DGX in Q3 2014 and has held it in 14 quarters since. The position peaked at $16.3M in Q2 2017. 631 funds tracked by Wall St. Rank hold DGX as of Q4 2017.
- AHL Partners held 117,920 shares of Quest Diagnostics worth $11.6M as of Q4 2017.
- AHL Partners bought 14,038 Quest Diagnostics shares in Q4 2017, an estimated $1.33M.
- Quest Diagnostics made up 0.18% of AHL Partners's portfolio in Q4 2017, its #152 holding.
- AHL Partners first reported a position in Quest Diagnostics in Q3 2014 and has held it in 14 quarters since.
- AHL Partners's Quest Diagnostics position peaked at $16.3M in Q2 2017.
- 631 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2017.
Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.